✦ LIBER ✦

Comparisons of patient characteristics in subpopulations of the OPtimising Transdermal Exelon In Mild-to-moderate Alzheimer's disease (OPTIMA) study

✍ Scribed by Frolich, Lutz; Monsch, Andreas; Kressig, Reto; Downs, Pamela; Caputo, Angelika; Strohmaier, Christine

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The rivastigmine high-dose, 13 mg/24h (1

✍ Cummings, Jeffrey; Bellelli, Giuseppe; Black, Sandra; Bakchine, Serge; Krahnke, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 119 KB

Predictors of response to the 13.3 and 9

✍ Molinuevo, J.L.; Grossberg, G.; Frölich, L.; Galvin, J.; Krahnke, T.; Strohmaier 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 65 KB

Incidence and predictors of response to

✍ Molinuevo, Jose Luis; Grossberg, George; Frölich, Lutz; Galvin, James; Krahnke, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 150 KB

Efficacy of the 13.3 mg/24 h rivastigmin

✍ Black, Sandra; Bakchine, Serge; Bellelli, Giuseppe; Molinuevo, Jose Luis; Downs, 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 82 KB

Acceptability, safety and feasibility of

✍ Frederiksen, Kristian; Sobol, Nanna; Beyer, Nina; Madsen, Karine; Law, Ian; Gard 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 116 KB

Disease progression in patients with mil

✍ Gaudig, Maren; Richarz, Ute; Rettig, Klaus; Djelani, Miriam; Schauble, Barbara 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 52 KB